Compile Data Set for Download or QSAR
Report error Found 76 of ic50 data for polymerid = 1019
TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488058(N-(4-(4-(2- Methoxyethyl)piperazin- 1-yl)phenyl)-4...)
Affinity DataIC50: 1.30nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488080(N-(4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4- yl)...)
Affinity DataIC50: 2.70nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488104(N-(4-(4-Amino-4- ethylpiperidin-1- yl)phenyl)-4-(1...)
Affinity DataIC50: 3nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488093(3-((4-(2-((4- (Piperazin-1- yl)phenyl)amino) pyrim...)
Affinity DataIC50: 5.40nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488032(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 5.5nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488089(4-(1-(2,2- Difluoroethyl)-3- (pyridin-3-yl)-1H- py...)
Affinity DataIC50: 5.60nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488094(2-((4-(2-((4- (Piperazin-1- yl)phenyl)amino) pyrim...)
Affinity DataIC50: 5.60nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488039(N-(4-(4- (Cyclopropylmethyl) piperazin-1-yl)phenyl...)
Affinity DataIC50: 5.70nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488038(N-(4-(4- Cyclopropylpiperazin- 1-yl)phenyl)-4-(1- ...)
Affinity DataIC50: 6.10nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488079((4-((4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4- y...)
Affinity DataIC50: 6.30nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488054(2-Methyl-1-(4-(2-((2- methyl-1,2,3,4- tetrahydrois...)
Affinity DataIC50: 6.70nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488066(N-(4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4- yl)...)
Affinity DataIC50: 7.10nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488041(4-(1-(2- Methoxyethyl)-3- (pyridin-3-yl)-1H- pyraz...)
Affinity DataIC50: 7.5nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488059(N-(4-(4-(2- Methoxyethyl)piperazin- 1-yl)phenyl)-4...)
Affinity DataIC50: 7.5nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488050(N-(4-(4-(2-(2,2- Difluoroethoxy)ethyl) piperazin-1...)
Affinity DataIC50: 8nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488062(2-((4-(2-((4-(4-(2- Methoxyethyl)piperazin-1- yl)p...)
Affinity DataIC50: 9.20nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488099(N-(4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4- yl)...)
Affinity DataIC50: 9.40nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488090(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 9.40nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488075(1-(4-(4-((4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol...)
Affinity DataIC50: 9.90nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488065(N-(4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4- yl)...)
Affinity DataIC50: 10.7nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488098(N-(4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4- yl)...)
Affinity DataIC50: 10.9nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488074(1-(4-(4-((4-(1-ethyl-3- (pyridin-3-yl)-1H- pyrazol...)
Affinity DataIC50: 11nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488100(N-(4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4- yl)...)
Affinity DataIC50: 11nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488051(1-(4-(4-((4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol...)
Affinity DataIC50: 11.5nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488048(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 11.6nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488053(N-(4-(1-(2- Methoxyethyl)-3- (pyridin-3-yl)-1H- py...)
Affinity DataIC50: 12.6nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488037(2-(4-(4-((4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol...)
Affinity DataIC50: 13.2nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488029((4-((4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4- y...)
Affinity DataIC50: 13.5nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488042(N-(4-(1H-1,2,4- Triazol-1-yl)phenyl)- 4-(1-ethyl-3...)
Affinity DataIC50: 13.5nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488045(N-(4-(1H-Imidazol-1- yl)phenyl)-4-(1-ethyl- 3-(pyr...)
Affinity DataIC50: 13.6nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488033(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 13.9nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488069(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 14.3nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488073(N-(4-(4-(2- Methoxyethyl)piperazin- 1-yl)phenyl)-4...)
Affinity DataIC50: 14.5nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488046(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 14.7nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488036(N-(4-(1-Ethyl-1H- pyrazol-4-yl)phenyl)- 4-(1-ethyl...)
Affinity DataIC50: 15.1nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488092(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 16nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488101(2-(6-((4-(1-Ethyl-3- (pyridin-3-yl)-1H- pyrazol-4-...)
Affinity DataIC50: 16.3nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488078(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 16.3nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488088(4-(1-Ethyl-3-(5- fluoropyridin-3-yl)-1H- pyrazol-4...)
Affinity DataIC50: 17nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488056(4-(1-(2- Methoxyethyl)-3- (pyridin-3-yl)-1H- pyraz...)
Affinity DataIC50: 17nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488083(4-(1-(Oxetan-3-yl)-3- (pyridin-3-yl)-1H- pyrazol-4...)
Affinity DataIC50: 17.1nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488087(N-(4-(4- Aminopiperidin-1- yl)phenyl)-4-(1-ethyl- ...)
Affinity DataIC50: 17.3nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488081(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 17.7nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488060(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 18.5nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488030(2-Methyl-N-(4-(1- (oxetan-3-yl)-3- (pyridin-3-yl)-...)
Affinity DataIC50: 18.7nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488085(4-(1-Phenethyl-3- (pyridin-3-yl)-1H- pyrazol-4-yl)...)
Affinity DataIC50: 18.7nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488047(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 21nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488091(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 22.3nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488052(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 23.8nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetActivin receptor type-1 [R206H](Human)
Riken

US Patent
LigandPNGBDBM488044(4-(1-Ethyl-3-(pyridin- 3-yl)-1H-pyrazol-4- yl)-N-(...)
Affinity DataIC50: 24.9nMAssay Description:R206H: An overview of evaluation of an inhibitory effect of a compound of the present invention with respect to ALK2 (R206H) is as follows.In a buffe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: